Unfortunately, your browser is too old to work on this website. Please upgrade your browser
Skip to main content
Analysis

A growing gap? ICB variation in elective care waiting times in 2019 and 2025

Published 24 April 2026
Time to read clock icon About 15 mins
Authors

Key points

  • The Labour government has committed to restoring the 18-week standard for elective care by 2029. This would see at least 92% of waits being less than 18 weeks, a standard that has not been met for over a decade.
  • This analysis compares current elective care waiting times (2025) with pre-pandemic waiting times (2019) at the integrated care board (ICB) geography level to understand how they have changed and how they vary across England. We also explore changes in the volume of referrals, completed pathways and unreported removals between these two periods.
  • Waiting times across all ICBs worsened in 2025 when compared with 2019. In addition, the range in waiting times between the ICBs with the highest and lowest averages more than doubled between 2019 and 2025 – highlighting that where you live now increasingly influences how long you might have to wait for elective care.
  • We found no clear relationship between increases in waiting times in 2025 and those in 2019, ICB region or deprivation level – suggesting that other factors explain the larger increases in waiting times seen in some ICBs.
  • In 2025, completed pathways exceeded 2019 levels in all but two ICBs, suggesting activity had surpassed pre-pandemic levels. Referrals also rose in all but eight ICBs.
  • Unreported removals fell nationally, but there was much larger variation in trends across ICBs for this metric than for referrals or completed pathways – with many experiencing a 50% change in unreported removal numbers in 2025 compared with 2019. This more pronounced variation may reflect different underlying drivers.
  • Meeting the government’s ambition to restore the 18-week standard – and reduce geographic inequalities at the same time – will require targeted support for the ICBs that are lagging behind. 
 

Introduction

Waiting times for routine hospital care are a key measure of NHS performance – not least given the Labour government's commitment to restore the 18-week standard by 2029. This standard stipulates that 92% of elective care waits in England should be no longer than 18 weeks from referral to treatment. Our previous work shows that, at the national level, the government is likely to fall slightly short of these targets if current trends continue.

But a focus on national-level performance can mask substantial differences in waiting times between areas of England. Integrated care boards (ICBs) – the area-based NHS bodies responsible for planning local budgets and services – are a useful starting point to understand subnational variations in elective care performance and activity. However, trends are difficult to track due to frequent changes in the number of local commissioning organisations and their groupings since 2019, alongside changes in responsibilities between these organisations and NHS England. 

In this analysis, we examine variations in waiting times across ICB geographies to understand the extent of progress towards recovering pre-pandemic waiting times, including changes in referrals and activity. To do so, we analysed data from ICB footprints before the April 2026 boundary changes for 2025 and compared them with 2019 data by reconstructing ICB geographies. Throughout the findings, we focus on the 37 ICBs that had reliable data for both years (see Box 1).

 

Policy context

The NHS constitutional standard that 92% of patients in England should wait no more than 18 weeks between referral and starting treatment hasn’t been met for over a decade. Performance had been steadily declining for several years prior to the COVID-19 pandemic, which severely impacted the provision of elective care. During the initial COVID-19 outbreak, large volumes of routine hospital care were suspended to free up hospital beds. While the NHS restarted non-urgent services as early as April 2020, further waves of COVID-19 – alongside the wider impact of the pandemic – meant recovery to pre-pandemic activity levels was slow. It took until 2023/24 for the total number of completed care pathways per year to return to 2019/20 levels, having grown annually before the pandemic.

With waiting lists growing rapidly, the Conservative government made elective recovery a top priority from September 2021. The NHS was tasked with maximising activity and eliminating waits longer than 52 weeks. Several policy measures were introduced to enable this: expanding the use of advice and guidance (A&G) services, whereby GPs can seek specialist clinical advice before referring a patient onto the waiting list; increased use of independent-sector capacity to deliver NHS-funded care; substantial financial incentives to encourage the recovery of elective activity; and capital funding for new community diagnostic centres and elective care hubs. 

Labour has expanded many of these measures since coming to power in 2024 – although revised financial incentives with the aim of providing trusts greater funding certainty. The government has also committed to an equitable recovery of elective care alongside a highly ambitious pledge to return to the 18-week standard by the end of the parliament. Both of these commitments will require sustained increases in activity.  

ICBs should play a key role by working with local NHS services to increase capacity, manage demand and address health inequalities. Their collaboration will be needed to achieve this through approaches such as supporting service transformation to shift care to community settings, redesigning referral pathways and embedding equity into planning and commissioning decisions. However, as ICBs are no longer responsible for overseeing trust performance, they will have reduced influence over their running. While changes are underway to the number of ICBs and their boundaries, there were 42 ICBs in England at the time of our analysis. These varied substantially in terms of geographical reach and the size, composition and needs of the population they served. For example, some ICBs had older populations with a higher prevalence of comorbidities and therefore a higher need for elective care. Furthermore, ICBs vary in organisational complexity, which affects their elective recovery approaches. These variations in geography, organisational complexity and rate of change are all expected to contribute to the variation seen in waiting times across ICBs. 

As of December 2025, waiting times for elective care still hadn’t recovered from the COVID-19 pandemic, with only 61.5% of waits falling within the 18-week standard – far behind the 83% in December 2019. Reaching the 92% standard in the next 3 years is an ambitious goal that will require progress across all ICBs.

Data 

For this analysis, we used monthly Referral to Treatment (RTT) waiting times data, accessed through the UK Health Facts Database (hosted by Facts and Dimensions). We extracted data on the number of new RTT periods, completed pathways and incomplete pathways for each ICB and each speciality for every month from January 2019 to December 2025. New RTT periods mostly consist of referrals – we refer to the data for ‘new RTT periods’ as referrals for ease of understanding. For the period before ICBs were formed, we aggregated organisational codes at the clinical commissioning group (CCG) level to create the same geographies as the ICBs they subsequently formed. A code list was used. 

Approach

We included all specialities except oral surgery. Responsibility for commissioning secondary dental services changed from NHS regional commissioning hubs to ICBs in April 2023, so 2019 and 2025 volumes are not directly comparable at the ICB level. We excluded the ‘oral surgery’ specialty to account for the majority of secondary dental services. Less than 1% of secondary dental activity is likely captured in other specialities (for example, ‘other – surgical services’), meaning 2025 volumes may be slightly overestimated. The median waiting times and total counts of referrals, completed pathways and unreported removals used in this analysis were calculated excluding oral surgery, so they differ slightly from NHS England’s published figures. 

We estimated median waiting times for incomplete pathways at both the ICB and national levels. Each week-long waiting-time band was assigned a midpoint (for example, 4.5 weeks for pathways open for 4–5 weeks and 104.5 weeks for the open-ended 104+ week band in the months after April 2021; for months pre-April 2021, we assigned a value of 52.5 weeks to the open-ended 52+ week band). We estimated the median waiting time in a given month by ordering pathways by their midpoint and identifying the point where half of all pathways were waiting less than or equal to that time. A year mean average of monthly median waiting times was calculated for 2019 and 2025. 

To better understand recovery of elective care activity, we calculated the percentage change in referrals onto the waiting list, completed pathways (admitted and non-admitted) and unreported removals between 2019 and 2025 for each ICB. The extent of deprivation for each ICB was calculated as the proportion of Lower layer Super Output Areas in the ICB that are in the most deprived decile according to the Index of Multiple Deprivation 2025. Deprivation-related associations were assessed using R-squared. Region-related associations were identified by observing the distribution of ICBs based on their region.  

Limitations

We were not able to explain changes in waiting times data for all ICBs over our study period. Four ICBs (Cambridgeshire and Peterborough ICB, Gloucestershire ICB, North Central London ICB, West Yorkshire ICB) saw step changes in their time-series data for total referrals, completed pathways or incomplete pathways during 2019. These changes may have been due to CCG mergers, changes in electronic patient records systems or data quality issues and invalidate a direct comparison of total volumes in 2019 and 2025. South Yorkshire ICB was affected by the lack of data reporting from Sheffield Teaching Hospitals in 2025. Therefore, we did not include these ICBs in our analysis, but their volumes of referrals/completed pathways are included in our calculation of national averages. Throughout the analysis, we consider the 37 ICBs for which we have reliable data in both 2019 and 2025. 

 

Findings

How elective care waiting times have changed since 2019 across ICBs

We compared median waiting times in 2025 with those in 2019. Median waiting time is the most representative measure of people’s experience but varies substantially across specialties and between areas of the country. 

While median waiting times had been gradually increasing since 2015, between 2019 and 2025, the national median waiting time grew rapidly – increasing by 82% (from 7.4 weeks in 2019 to 13.5 weeks in 2025). All ICBs saw an increase in median waiting time, from between 6.1–8.9 weeks in 2019 to between 10.1–16.8 weeks 2025. The range between the ICBs with the highest and lowest median waits more than doubled between 2019 and 2025, increasing from 2.8 weeks in 2019 to 6.7 weeks in 2025. As Figure 1 shows, the extent of this increase varied substantially, with median waiting times increasing by around 50% in some ICBs while more than doubling in others. 

Several factors shape waiting times, such as the size of the waiting list and the complexity of cases as well as referral and activity rates. Some ICBs saw much larger increases in waiting times than others despite having similar median waits in 2019. These differences are likely due to a combination of factors, which will vary between ICBs. ICBs with the highest median waiting times in 2019 tended to have the smallest relative increases thereafter – perhaps because their already high waiting times lead them to prioritise long waits. 

Figure 1

Looking at median waiting times can mask the number of people waiting for longer. To get a better picture of this, we analysed the percentage of elective care waits that were within the 18-week standard. 

In 2025, only 61% of all waits were within the 18-week standard nationally, compared with 86% in 2019. At the ICB level, there was substantial variation, which increased between 2019 and 2025 – from a range of 13 percentage points to 19 percentage points. In 2019, the percentage of waits within 18 weeks ranged from 79% to 92% on average. By 2025, this percentage had fallen substantially for all ICBs, ranging from 52% to 71% (Figure 2). Some of the ICBs with the highest percentages of waits within 18 weeks in 2019 had seen the largest decreases in this key metric by 2025.

Two-fifths of ICBs (15 of 37) had less than 60% of waits within 18 weeks on average in 2025, highlighting the significant challenge of returning to the 92% standard by 2029.

Figure 2

How referrals, completed pathways and unreported removals have changed

We compared the volumes of referrals, completed pathways and unreported removals at the ICB level in 2025 with those in 2019. Here, we look at whether changes were more pronounced based on an ICB’s region or deprivation level.

Waiting times are affected by the size of the waiting list. This is a product of how quickly people are added to the waiting list, most commonly through referrals from their GP, and how quickly they leave the waiting list, mainly through completing their care pathway. Care pathways are usually completed following the initiation of treatment or a decision not to treat, although there are other reasons a pathway may end. Around 15% of all pathways end without a completed pathway being recorded – these are known as ‘unreported removals’. This could be because a patient’s care wasn’t recorded within the system until a few months later, or because a clinical review of patient notes determined no additional care was needed. New referrals have consistently outnumbered completed pathways since elective care data have been reported; therefore, unreported removals have played a key role in the overall decrease in the waiting list observed in the last few years.  

Referrals

The volume of referrals increased in most ICBs when comparing 2025 with 2019. This is consistent with a growing and ageing population with an increasing prevalence of multimorbidity, alongside earlier diagnoses and improved treatment options. In 30 of 37 ICBs, referrals increased by between 1% and 26% (Figure 3). However, eight ICBs saw a decrease in referrals of between 1% and 13%. Three of these ICBs included 10 of the 20 Further Faster trusts, a programme aimed at improving elective care performance, including through reducing unnecessary referrals. A&G services also aim to reduce unnecessary referrals by allowing GPs to seek specialist advice prior to or instead of referral. However, we found that ICBs that had declines in referrals did not have more pre-referral diversions through A&G in 2025 relative to total referrals. 

Figure 3

Completed pathways

Almost all of the ICBs (35 of 37) saw an increase in their total number of completed pathways in 2025 compared with 2019 (Figure 4). At the national level, the number of completed pathways increased by 9.9% between these years, but some ICBs saw a much larger increase, with seven seeing an increase of more than 20%. Two ICBs had fewer completed pathways in 2025 than in 2019. 

Pathways are completed in either admitted (inpatient or day case) or non-admitted settings. Completed non-admitted pathways include those completed for reasons other than the start of definitive treatment, such as a clinical decision to refer back to GP care or not to treat, as well as those completed as a result of treatment starting in an outpatient setting. Completed non-admitted pathways make up around 80% of all completed pathways and therefore account for most of the change in completed pathway volume when comparing 2025 with 2019. 

Nationally, there was a larger increase in completed non-admitted pathways (11%) compared with completed admitted pathways (6%). This may be due to the additional challenges involved with expanding admitted activity, including more complex cases and inpatient capacity constraints, as well as a general trend towards more pathways being completed in non-admitted settings. This trend is reflected at the ICB level – 11 ICBs saw a decline in their completed admitted pathways volume, while only six saw a decline in their completed non-admitted pathways volume (Figure 4). 

Figure 4

Unreported removals

Nationally, unreported removals were 5.2% lower in 2025 compared with 2019, but again we observed substantial variation across ICBs. 12 of 35 ICBs had a change of more than 50% in their annual volume of unreported removals between 2019 and 2025 (Figure 5). Two ICBs were excluded from this part of the analysis as they had negative numbers of unreported removals in most months in 2025, raising concerns about data quality. In addition, large percentage changes in some ICBs were driven by small numbers of unreported removals in 2019 or 2025. 

The more pronounced variations in unreported removals than in referrals and completed pathways may reflect different underlying drivers. While some unreported removals – for example, completed pathways recorded with a delay – are constrained by hospital activity, others – for example, those caused by changes in electronic patient record systems and data validation processes – can vary more markedly from year to year. 

A decline in unreported removals for 21 out of 37 ICBs may have been due to improved data collection processes identifying more completed pathways without a delay. In some ICBs, changes in electronic patient record systems produced artificially high numbers of unreported removals in 2019, resulting in declines when compared with 2025 volumes. Completed pathways and unreported removals combined represent the total removals from the waiting list. Therefore, whether finished pathways are recorded as completed or left unreported can affect how an ICB’s volume of activity is understood. Unreported removals made up a smaller proportion of all removals from the waiting list in 2025 (15%) compared with 2019 (18%). Thus, changes to unreported removals – especially where driven by improvements to reporting – and genuine increases in activity may both be drivers of the increases seen in completed pathways in 2025 when compared with 2019. 

Figure 5

Summary of findings and how they are related

Overall, activity levels in 2025 – measured through completed pathways – were above the levels seen in 2019, nationally and for most ICBs. Referral volumes were also above 2019 levels nationally and for all but eight ICBs. Unreported removals, however, decreased by 5.2% across England. They also saw greater levels of variation across ICBs, with many experiencing a more than 50% change in their volume of unreported removals between 2019 and 2025. We found that changes in referrals, completed pathways and unreported removals were not associated with ICB region or deprivation level.     

Many factors shape trends in waiting times, including referrals onto and removals from the waiting list and the composition of the waiting list over time. This analysis looked at ICBs in 2019 and 2025 but not at the years in between nor the composition of waiting lists in 2019. The magnitude of COVID-19 disruption and the lag in elective care recovery across ICBs likely also shaped trends in waiting times in 2025. Therefore, changes in referrals and removals do not fully account for the variation observed across ICBs. 

 

Discussion

Widening variation in waiting times for elective care

Our analysis shows that elective care waiting times worsened substantially between 2019 and 2025, and they varied across ICBs far more in 2025 than in 2019. These findings highlight that where people live has become a bigger factor in shaping how long they wait for elective care since the COVID-19 pandemic. The government's pledge to restore the 18-week standard by 2029 is unlikely to be met nationally unless all ICBs can deliver substantial improvements. With the operational standard set at 92% (to allow for clinical exceptions and patient choice), the scope for ICBs that exceed the standard to offset underperformance elsewhere is fundamentally limited. The government simply cannot afford for any ICBs to be left behind. 

Changes in referrals and elective care activity across ICBs

The volume of referrals increased in most ICBs in 2025 compared with 2019, although eight ICBs saw referrals decrease by 1–13%. Lower referral volumes may be partly due to service changes, though they do not appear to be due to higher use of A&G before referrals in these ICBs. It is hard to know the true contribution of A&G in limiting inappropriate referrals, as there are incentives for GPs to use A&G, and some may use A&G when no referral would have been made in its absence. 

Our previous projections show elective health care demand is likely to increase by 1.4% annually between 2024/25 and 2034/35 due to increases in population, comorbidities and age. Therefore, further work is needed to understand whether the decline in referrals in some ICBs represents an appropriate use of alternative services or a growing unmet need for elective care.

While it is encouraging that the volume of total completed pathways has increased in most parts of England, there are major differences between ICBs. Some have substantially exceeded 2019 activity levels, while others have only just met the 2019 volume. Several factors may have shaped these disparities. Prior to COVID-19, inequalities in access to elective care were already growing, and the impact of the pandemic was not evenly distributed across England. Other factors likely played a role, such as the ‘financial reset’ initiated by NHS England for 2025/26, differences in access to local independent sector health care services and the extent to which ICBs could take advantage of financial incentives. Further analysis is needed to understand whether some of the policies introduced to support elective care recovery may have boosted national performance while contributing to widening differences between ICBs.   

System changes and recovery challenges

There have been even bigger differences between ICBs in terms of unreported removals. Nationally, the volume of unreported removals in 2025 was lower than in 2019 (unlike referrals and completed pathways) – this may be due to more timely reporting of completed pathways. Variation in changes to unreported removals across ICBs was likely partially due to different approaches to the validation of waiting lists and temporary disruptions caused by the adoption of new electronic patient record systems. However, the lack of information on unreported removals within publicly available data makes it difficult to know, for example, how unreported removals resulting from validation exercises compare with previous years. NHS England needs to routinely report the breakdown of unreported removals to enable the more effective monitoring of changes in total elective care activity. 

This month, planned ICB mergers and clustering arrangements have reduced the number of ICBs from 42 to 26. As some ICBs’ population sizes increase, our ability to identify inequalities between areas of England at a granular level using ICB data will be limited. This will make it harder to identify areas lagging behind that would benefit from additional support. A forthcoming Health Foundation analysis will explore demographic inequalities in elective care waits and how ICB changes will affect how we understand these inequalities.

With reduced visibility of place-based inequalities, it will become even more important to address variation across ICBs. As this variation is driven by unequal performance across the trusts delivering care within each integrated care system, action is needed at the trust level. The government’s recently announced NHS intensive recovery programme – focusing on five trusts with ‘structural challenges’ – is a welcome recognition that some parts of the country need additional support to meet performance targets. However, the type of support provided will be key – for example, the proposal to make leadership changes in these trusts may not have the desired effect without the inclusion of additional resources.   

The widening variation in elective care waiting times highlights the scale of the challenge to return to the 18-week standard and deliver equitable recovery of elective care. The government must ensure it reduces inequalities in access to health care as part of elective care recovery so that where you live doesn’t affect how long you have to wait for care. 

Acknowledgements

We are grateful to the Elective Recovery Analysis and Modelling team at NHS England for their feedback on our analysis.

Further reading

Related content